Trial Profile
Phase III Clinical Trial to Evaluate the Antiviral Activity and Safety of DA-2802(Tenofovir Disoproxil Orotate) and Viread(Tenofovir Disoproxil Fumarate) in Chronic Hepatitis B Patients
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 25 Mar 2022
Price :
$35
*
At a glance
- Drugs Tenofovir disoproxil orotate (Primary) ; Tenofovir disoproxil fumarate
- Indications Hepatitis B
- Focus Therapeutic Use
- Sponsors Dong-A ST
- 12 Mar 2022 Primary endpoint has been met (Difference of HBV DNA level(log10), as per Results published in the Journal of Korean Medical Science
- 12 Mar 2022 Results published in the Journal of Korean Medical Science
- 13 Apr 2021 Status changed from recruiting to completed.